ARCHIVES

FDA Throws Up IND Roadblock, Then Refuses To Answer Investigator’s Letters About It

This article is from The Cancer Letter archive.

Vol. 02 No. 06 | February 6, 1976

Download PDF Visit The Full Archive

Related Articles

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

In Brief: Mueller, Rosenberg Head AACR; Elion, Schein Presidents Elect; PHS Offers epidemiology Training

May 7, 1982

Advisors approve NCI’s revised plan for $104-million proteomics research program.

July 8, 2005

In Brief: PCORI Forms Clinical Trials Advisory Board

April 4, 2014

Study Finds No Evidence That Statins Cut Cancer Risk

January 27, 2006

Clinical Oncology Programs Extended Two Years; No Decision Yet On Further Expansion

November 3, 1978